menu

Medical Industry Feature: Breast Cancer: When May Neoadjuvant Therapy Be the Right Choice?

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
Merck Oncology

Breast Cancer: When May Neoadjuvant Therapy Be the Right Choice?

Program Information
Recommended
Breast Cancer: When May Neoadjuvant Therapy Be the Right Choice?
RestartResume
How do you identify an appropriate candidate for neoadjuvant systemic therapy?
  • Sponsored by

  • Overview

    Neoadjuvant therapy is an effective strategy in treating breast cancer—for some patients. How can clinicians best identify treatment options for their patients? What factors should be considered? 

    In this Medical Industry Feature, join Dr. Heather McArthur, a medical oncologist who specializes in treating breast cancer, as she discusses best practices to follow when considering and implementing neoadjuvant treatment strategies appropriate for your patients.

    ONCO-1263982-0003 11/18

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 9/21/19

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.